The Association and Interaction of Aldehyde Dehydrogenase 2 Polymorphisms with Food Group Intake and Probability of Having Non-Alcoholic Fatty Liver Disease

Código QR

The Association and Interaction of Aldehyde Dehydrogenase 2 Polymorphisms with Food Group Intake and Probability of Having Non-Alcoholic Fatty Liver Disease

Xiaoyan Hao, Qiang Zeng Health Management Institute, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, People’s Republic of ChinaCorrespondence: Qiang ZengHealth Management Institute, The Second Medical Cent...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hao X, Zeng Q
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	rs671 nash genotype foods Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/0fd2079e2a754245908ef33f4af5ec31
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The Circulating Micro-RNAs (−122, −34a and −99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases
por: Hendy OM, et al.
Publicado: (2019)

Study of Cytochrome P450 2E1 and its allele Variants in Liver Injury of Nondiabetic, Nonalcoholic Steatohepatitis Obese Women
por: VARELA,NELSON M, et al.
Publicado: (2008)

Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice
por: David-Silva A, et al.
Publicado: (2020)

A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis
por: Ganguli S, et al.
Publicado: (2019)

Risk of Non-Alcoholic Fatty Liver Disease in Xanthelasma Palpebrarum
por: Chen HW, et al.
Publicado: (2021)

Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
por: Rocío Gallego-Durán, et al.
Publicado: (2021)

Aldehyde dehydrogenase 2 rs671G>A polymorphism and ischemic stroke risk in Chinese population: a meta-analysis
por: Xu YL, et al.
Publicado: (2019)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress
por: Sue Shea, et al.
Publicado: (2021)

Influence of FTO rs9939609 polymorphism on appetite, ghrelin, leptin, IL6, TNFα levels, and food intake of women with morbid obesity
por: Magno FCCM, et al.
Publicado: (2018)

Combinations of alcohol-induced flushing with genetic polymorphisms of alcohol and aldehyde dehydrogenases and the risk of alcohol dependence in Japanese men and women.
por: Akira Yokoyama, et al.
Publicado: (2021)

Engineering Clostridial Aldehyde/Alcohol Dehydrogenase for Selective Butanol Production
por: Changhee Cho, et al.
Publicado: (2019)

Association of Aldehyde Dehydrogenase 2 Gene Polymorphism with Myocardial Infarction
por: Zhu LP, et al.
Publicado: (2021)

Arginase Gene Polymorphism Increases Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
por: Monika Buraczynska, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Jose D. Torres-Peña, et al.
Publicado: (2021)

Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver
por: Simone Carotti, et al.
Publicado: (2021)

FREQUENCY OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NEWLY DIAGNOSED CASES OF HEPATITIS C VIRUS INFECTION AND ITS CORRELATION WITH GENOTYPES IN NORMAL WEIGHT PATIENTS
por: Sultan Mehmood Kamran, et al.
Publicado: (2018)

Verapamil induces autophagy to improve liver regeneration in non-alcoholic fatty liver mice
por: Jian-Lin Lai, et al.
Publicado: (2021)

Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis
por: Sandip Mukherjee, et al.
Publicado: (2021)

Association between polymorphisms in SLC15A1 and PLA2G16 genes and development of obesity in Chinese subjects
por: Wang CY, et al.
Publicado: (2018)

Aldehyde-alcohol dehydrogenase forms a high-order spirosome architecture critical for its activity
por: Gijeong Kim, et al.
Publicado: (2019)

Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
por: Justine Gillard, et al.
Publicado: (2022)

Association of Serum Renalase Levels and Renalase rs10887800 Polymorphism with Unstable Angina Pectoris Patients Having Metabolic Syndrome
por: Izadpanah P, et al.
Publicado: (2020)

Relationship Between Serum Amyloid A1 (SAA1) Gene Polymorphisms Studies with Obesity in the Saudi Population
por: Alharbi KK, et al.
Publicado: (2021)

Association of FTO rs1421085 single nucleotide polymorphism with fat and fatty acid intake in Indonesian adults
por: Athraa Alaulddin Al-Jawadi, et al.
Publicado: (2021)

Equivalencia de Ingresos en un Duopolio Eléctrico
por: Alonso,Estrella, et al.
Publicado: (2010)

Novel Application of the Traditional Lipid Ratios as Strong Risk Predictors of NASH
por: Hegazy M, et al.
Publicado: (2020)

Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
por: Pegah Golabi, et al.
Publicado: (2022)

Mixed micelles loaded with the 5-benzylidenethiazolidine-2,4-dione derivative SKLB023 for efficient treatment of non-alcoholic steatohepatitis
por: Li Y, et al.
Publicado: (2019)

Filamentation of the bacterial bi-functional alcohol/aldehyde dehydrogenase AdhE is essential for substrate channeling and enzymatic regulation
por: Pauline Pony, et al.
Publicado: (2020)

Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis
por: Seko Y, et al.
Publicado: (2018)

Gut Microbiota Reshaped by Pectin Treatment Improves Liver Steatosis in Obese Mice
por: Camille Houron, et al.
Publicado: (2021)

Meat tenderness genetic polymorphisms occurrence and distribution in five Zebu breeds in Mexico
por: Parra-Bracamonte,Gaspar Manuel, et al.
Publicado: (2015)

Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease
por: José Ignacio Martínez-Montoro, et al.
Publicado: (2021)

Relationship Between Gallstone Disease and Cardiometabolic Risk Factors in Elderly People with Non-Alcoholic Fatty Liver Disease
por: Hung MC, et al.
Publicado: (2020)

No Association Between ADIPOQ or MTHFR Polymorphisms and Gestational Diabetes Mellitus in South African Women
por: Dias S, et al.
Publicado: (2021)

Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease
por: Chen L, et al.
Publicado: (2020)

The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity
por: Borges-Canha M, et al.
Publicado: (2021)

Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease
por: Liang XY, et al.
Publicado: (2021)

Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates
por: Philippe Garteiser, et al.
Publicado: (2021)

Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study
por: Lesmana CRA, et al.
Publicado: (2015)